News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
GlaxoSmithKline (JOBS) Settles U.S. Paxil Lawsuit for $40 Million
October 2, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, Oct 2 (Reuters) - GlaxoSmithKline has agreed to settle a long-standing U.S. case over its antidepressant Paxil by paying insurers $40 million to reimburse health plans that paid for children and adolescents to receive the drug.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Europe
GlaxoSmithKline
MORE ON THIS TOPIC
Drug pricing
Trump Wants To Bring Back International Drug Pricing Policy:
Reuters
April 23, 2025
·
2 min read
·
Annalee Armstrong
Policy
RFK Considers Pulling COVID-19 From CDC’s Vaccine Guidelines for Children:
Politico
April 23, 2025
·
2 min read
·
Tristan Manalac
Legal
Lilly Takes Four Compounders to Court for Allegedly Producing Knockoff Tirzepatide
April 23, 2025
·
2 min read
·
Tristan Manalac
FDA
Makary Discusses Expedited Rare Disease Approvals Pathway, ‘Public Distrust’ in New Interview
April 21, 2025
·
2 min read
·
Tristan Manalac